
ST AIA-PACK CEA is designed for in-vitro
Part #: 0025254
Manufacturers:
Carcinoembryonic antigen (CEA), is normally present at very low concentration in the blood of healthy adults. The level of serum CEA is elevated in many gastrointestinal cancers, such as, colon cancer, pancreatic cancer and gastric cancer, and there have been some positive cases of lung cancer, uterine cancer, ovarian cancer and embryonic carcinoma. Since the positive rate is low in benign diseases, CEA assay is widely used as an effective clinical test for diagnosing, assessing therapeutic effects and monitoring these malignancies. Preoperative CEA levels may be of prognostic value since the level of elevation is correlated with body burden of tumor.
Technical specifications
| Kit name | ST AIA-PACK CEA |
| Method | Enzyme Immunoassay (EIA) |
| Assay principle | Two-site immunoenzymometric assay |
| Assay sample | Serum or heparinized plasma |
| Calibrators | 0, 50 ng/mL |
| Standardization | WHO 1st IRP 73/601 |
| Calibration stability | 90 days |
| Assay range | 0.5 - 100 ng/mL |
| Reaction time | 10 minutes |
| Hook effect | >20,000 ng/mL |
| Storage | 2 - 8oC |
Refer to the product Instruction-For-Use (IFU) for complete details.